common.skip_to_content
USE CODE MUNCHMAKERS FOR 10% OFF YOUR FIRST ORDER INFO@MUNCHMAKERS.COM
Sign in Request a quote Cart
USE MUNCHMAKERS FOR 10% OFF YOUR FIRST ORDER
Grinders from MunchMakers MunchMakers · Custom Grinders Custom grinders that sell themselves Laser-engraved aluminum grinders with your logo. Retail them or gift them with big orders. See custom grinders →

Med-X Resurfaces With New Stock Promotion Campaign After 2016 Flop

Same management team behind failed $15M crowdfunding attempt now running aggressive promotion on Stockhouse

Lighters from MunchMakers MunchMakers · Custom Lighters Logo lighters your customers pocket Custom-printed lighters travel further than any flyer. Bulk pricing for dispensaries. See custom lighters →
Med-X Resurfaces With New Stock Promotion Campaign After 2016 Flop

A cannabis company that attempted to raise $15 million through an aggressive crowdfunding campaign in 2016 has resurfaced with a new stock promotion effort, raising red flags for industry observers.

Med-X, which originally sought to sell 21% of its ownership through a Regulation A+ offering a decade ago, is now being promoted heavily on Stockhouse under the same management team that led the failed 2016 campaign. The company's reemergence comes as cannabis investors face increasing scrutiny over promotional stock schemes in the sector.

The original 2016 crowdfunding effort drew criticism from industry analysts who questioned both the valuation and the aggressive marketing tactics employed. Regulation A+ offerings, often called "mini-IPOs," allow companies to raise up to $75 million from both accredited and non-accredited investors with less regulatory oversight than traditional public offerings.

The Pattern Repeats

The current promotional push on Stockhouse, a Canadian financial forum and stock promotion platform, mirrors tactics that have historically preceded problematic cannabis stock plays. Stockhouse has faced scrutiny in the past for allowing paid promotions that blur the line between genuine investor discussion and coordinated marketing campaigns.

Med-X's persistence with the same leadership team raises questions about lessons learned from the 2016 attempt. The cannabis industry has evolved significantly since then, with major regulatory changes and a more mature investor base that has witnessed numerous pump-and-dump schemes and promotional failures.

The company's renewed efforts come at a time when cannabis stock investors have grown more cautious. The sector saw a wave of promotional plays during the 2018-2019 bubble, many of which left retail investors with significant losses.

What Investors Should Know

Regulation A+ offerings remain a legitimate fundraising mechanism, but aggressive promotion campaigns often signal elevated risk. The SEC requires companies to file offering statements and provide regular updates, but enforcement of promotional activities remains inconsistent.

Industry veterans recommend scrutinizing management track records, actual revenue figures, and the ratio of promotional spending to operational investment. Companies that spend more on marketing their stock than building their business often follow predictable patterns.

The cannabis sector continues to attract both legitimate operators and promotional vehicles. The distinction often lies in whether companies focus on operational milestones or stock price momentum.


This article is based on original reporting by www.newcannabisventures.com.

More from Alex Morgan